Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
98 | Pathology and Oncology Research | journal | 0.716 Q3 | 61 | 104 | 635 | 4010 | 1534 | 597 | 2.18 | 38.56 | 44.34 | |
97 | Cancer Genomics and Proteomics | journal | 0.722 Q3 | 50 | 65 | 197 | 4039 | 516 | 197 | 2.80 | 62.14 | 32.92 | |
96 | Sub-Cellular Biochemistry | journal | 0.726 Q3 | 81 | 65 | 120 | 9603 | 452 | 1 | 3.01 | 147.74 | 0.00 | |
95 | Oncology Reviews | journal | 0.747 Q3 | 31 | 16 | 49 | 1257 | 158 | 48 | 2.67 | 78.56 | 42.62 | |
94 | Nitric Oxide - Biology and Chemistry | journal | 0.749 Q3 | 110 | 48 | 211 | 4099 | 746 | 209 | 3.24 | 85.40 | 41.98 | |
93 | Epigenomics | journal | 0.751 Q3 | 77 | 100 | 420 | 6506 | 1140 | 390 | 2.27 | 65.06 | 45.14 | |
92 | Molecular Imaging and Biology | journal | 0.752 Q3 | 78 | 125 | 364 | 5604 | 999 | 346 | 2.79 | 44.83 | 38.09 | |
91 | Current Problems in Cancer | journal | 0.759 Q3 | 47 | 50 | 226 | 2582 | 551 | 216 | 2.48 | 51.64 | 51.07 | |
90 | European Journal of Cancer, Supplement | journal | 0.759 Q3 | 29 | 0 | 14 | 0 | 31 | 13 | 0.33 | 0.00 | 0.00 | |
89 | Medical Oncology | journal | 0.763 Q3 | 90 | 359 | 520 | 23351 | 1600 | 500 | 3.02 | 65.04 | 40.77 | |
88 | FASEB BioAdvances | journal | 0.764 Q3 | 18 | 40 | 210 | 1940 | 560 | 202 | 2.52 | 48.50 | 41.53 | |
87 | Brain Tumor Pathology | journal | 0.776 Q3 | 45 | 27 | 86 | 922 | 237 | 76 | 2.58 | 34.15 | 22.16 | |
86 | Molecular Medicine Reports | journal | 0.781 Q3 | 86 | 223 | 2030 | 8889 | 6752 | 2030 | 3.23 | 39.86 | 42.67 | |
85 | JMIR Cancer | journal | 0.790 Q3 | 24 | 57 | 163 | 2586 | 538 | 163 | 3.26 | 45.37 | 59.05 | |
84 | Leukemia and Lymphoma | journal | 0.790 Q3 | 102 | 309 | 1482 | 9499 | 2278 | 916 | 1.50 | 30.74 | 44.90 | |
83 | Cancer Treatment and Research Communications | journal | 0.793 Q3 | 23 | 107 | 477 | 4244 | 1166 | 459 | 2.49 | 39.66 | 45.10 | |
82 | Human Cell | journal | 0.805 Q2 | 44 | 188 | 480 | 9999 | 1598 | 445 | 3.30 | 53.19 | 40.06 | |
81 | Hematological Oncology | journal | 0.820 Q2 | 54 | 143 | 344 | 5325 | 778 | 271 | 2.29 | 37.24 | 48.23 | |
80 | Virus Research | journal | 0.825 Q2 | 144 | 245 | 774 | 13061 | 3007 | 770 | 2.75 | 53.31 | 45.21 | |
79 | International Journal of Hyperthermia | journal | 0.827 Q2 | 98 | 139 | 540 | 5768 | 1730 | 523 | 3.02 | 41.50 | 43.45 | |
78 | Oncology | journal | 0.832 Q2 | 107 | 85 | 276 | 2687 | 771 | 270 | 2.50 | 31.61 | 28.12 | |
77 | Clinical and Translational Oncology | journal | 0.837 Q2 | 61 | 349 | 747 | 19032 | 2290 | 717 | 3.04 | 54.53 | 45.76 | |
76 | Oncology Reports | journal | 0.864 Q2 | 115 | 201 | 989 | 10433 | 3526 | 989 | 3.24 | 51.91 | 39.03 | |
75 | Cancer Chemotherapy and Pharmacology | journal | 0.869 Q2 | 122 | 109 | 496 | 3935 | 1395 | 488 | 2.73 | 36.10 | 37.56 | |
74 | Tumour Virus Research | journal | 0.904 Q2 | 34 | 17 | 49 | 1333 | 208 | 47 | 4.94 | 78.41 | 43.14 | |
73 | Cancer Biology and Therapy | journal | 0.914 Q2 | 130 | 83 | 267 | 3691 | 956 | 263 | 4.32 | 44.47 | 45.15 | |
72 | Cancer journal (Sudbury, Mass.) | journal | 0.933 Q2 | 102 | 55 | 218 | 3810 | 493 | 200 | 2.51 | 69.27 | 38.30 | |
71 | Cancer Causes and Control | journal | 0.934 Q2 | 147 | 149 | 381 | 5689 | 878 | 369 | 2.24 | 38.18 | 63.25 | |
70 | Clinical Breast Cancer | journal | 0.942 Q2 | 80 | 165 | 503 | 6540 | 1521 | 480 | 3.01 | 39.64 | 50.25 | |
69 | Journal of Mammary Gland Biology and Neoplasia | journal | 0.964 Q2 | 112 | 24 | 80 | 1765 | 228 | 75 | 2.77 | 73.54 | 49.15 | |
68 | Function | journal | 0.987 Q2 | 16 | 74 | 173 | 3180 | 401 | 136 | 2.18 | 42.97 | 39.01 | |
67 | Current Opinion in Oncology | journal | 0.990 Q2 | 104 | 85 | 290 | 4473 | 919 | 267 | 2.68 | 52.62 | 44.00 | |
66 | Cancer cytopathology | journal | 0.991 Q2 | 68 | 107 | 375 | 2808 | 1003 | 253 | 2.53 | 26.24 | 46.36 | |
65 | Current Hematologic Malignancy Reports | journal | 0.998 Q2 | 44 | 31 | 130 | 2271 | 402 | 130 | 2.83 | 73.26 | 46.74 | |
64 | World Journal of Oncology | journal | 1.009 Q2 | 10 | 68 | 101 | 2257 | 448 | 95 | 2.33 | 33.19 | 44.24 | |
63 | Familial Cancer | journal | 1.016 Q2 | 67 | 54 | 138 | 1749 | 305 | 131 | 2.28 | 32.39 | 56.95 | |
62 | Journal of Cancer Research and Clinical Oncology | journal | 1.023 Q2 | 109 | 1481 | 946 | 64519 | 3353 | 901 | 3.31 | 43.56 | 42.09 | |
61 | Future Oncology | journal | 1.029 Q2 | 90 | 244 | 1139 | 8090 | 3137 | 1076 | 2.78 | 33.16 | 39.46 | |
60 | Molecular Carcinogenesis | journal | 1.034 Q2 | 107 | 153 | 283 | 6920 | 1042 | 282 | 3.25 | 45.23 | 43.32 | |
59 | Cancer Drug Resistance | journal | 1.035 Q2 | 24 | 47 | 210 | 5023 | 844 | 205 | 4.27 | 106.87 | 45.99 | |
58 | Seminars in Radiation Oncology | journal | 1.038 Q2 | 103 | 46 | 134 | 3187 | 426 | 124 | 2.68 | 69.28 | 40.72 | |
57 | Frontiers in Oncology | journal | 1.066 Q2 | 136 | 5104 | 16279 | 252112 | 61381 | 15902 | 3.43 | 49.39 | 43.03 | |
56 | Carcinogenesis | journal | 1.074 Q2 | 223 | 80 | 444 | 3785 | 1640 | 430 | 3.28 | 47.31 | 41.20 | |
55 | Cancer Epidemiology | journal | 1.075 Q2 | 86 | 143 | 492 | 5876 | 1242 | 468 | 2.45 | 41.09 | 51.33 | |
54 | Cytotherapy | journal | 1.084 Q2 | 105 | 155 | 345 | 7941 | 1252 | 327 | 3.60 | 51.23 | 43.81 | |
53 | BMC Cancer | journal | 1.087 Q2 | 160 | 1237 | 3866 | 50992 | 13894 | 3864 | 3.34 | 41.22 | 42.48 | |
52 | International Journal of Oncology | journal | 1.099 Q2 | 139 | 129 | 526 | 10371 | 2380 | 525 | 4.04 | 80.40 | 41.69 | |
51 | Genes Chromosomes and Cancer | journal | 1.110 Q2 | 130 | 83 | 250 | 3483 | 843 | 243 | 3.39 | 41.96 | 45.09 | |
50 | Advances in Biological Regulation | journal | 1.114 Q2 | 69 | 39 | 111 | 2651 | 395 | 105 | 2.77 | 67.97 | 43.71 | |
49 | Journal of Neuro-Oncology | journal | 1.131 Q2 | 135 | 322 | 818 | 11847 | 3066 | 796 | 3.51 | 36.79 | 34.85 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®